Tevogen Bio Holdings (TVGN) Prepaid Assets (2021 - 2026)
Tevogen Bio Holdings (TVGN) reported Prepaid Assets of $1.3 million for Q1 2026, up 36.63% on a YoY basis from $944056.0 in Q1 2025, and up 55.67% quarter-over-quarter from $828592.0 in Q4 2025.
Tevogen Bio Holdings (TVGN) Prepaid Assets (2021 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Prepaid Assets for 6 years, with the latest figure at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 36.63% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 36.63% YoY), and the FY2025 full-year result was $828592.0, down 9.85% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.3 million, up from $828592.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.3 million in Q1 2026, with the low at $44781.0 in Q1 2023.
- Historically, Prepaid Assets has averaged $675364.4 across 5 years, with a median of $828592.0 in 2025.
- Annual changes were most pronounced in 2023 — Prepaid Assets plunged 91.09% — and 2024, when it surged 1961.59%.
- Tevogen Bio Holdings' Prepaid Assets stood at $145170.0 in 2022, then surged by 361.93% to $670582.0 in 2023, then soared by 37.06% to $919088.0 in 2024, then retreated by 9.85% to $828592.0 in 2025, then soared by 55.67% to $1.3 million in 2026.
- The last three Prepaid Assets figures came in at $1.3 million (Q1 2026), $828592.0 (Q4 2025), and $925821.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 828,592.00 |
| Sep 30, 2025 | 925,821.00 |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 944,056.00 |
| Dec 31, 2024 | 919,088.00 |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 923,202.00 |
| Dec 31, 2023 | 670,582.00 |
| Sep 30, 2023 | 51,928.00 |
| Jun 30, 2023 | 143,317.00 |
| Mar 31, 2023 | 44,781.00 |
| Dec 31, 2022 | 145,170.00 |
| Sep 30, 2022 | 275,426.00 |
| Jun 30, 2022 | 409,110.00 |
| Mar 31, 2022 | 502,613.00 |
| Dec 31, 2021 | 446,610.00 |